516 related articles for article (PubMed ID: 23265145)
1. Methylnaltrexone for the treatment of opioid-induced constipation.
Bader S; Dürk T; Becker G
Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):13-26. PubMed ID: 23265145
[TBL] [Abstract][Full Text] [Related]
2. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?
Holzer P
Curr Pharm Des; 2012; 18(37):6010-20. PubMed ID: 22747544
[TBL] [Abstract][Full Text] [Related]
3. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006332. PubMed ID: 29869799
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic treatment of opioid-induced constipation.
Wang CZ; Yuan CS
Expert Opin Investig Drugs; 2013 Oct; 22(10):1225-7. PubMed ID: 23834367
[TBL] [Abstract][Full Text] [Related]
5. Methylnaltrexone: treatment for opioid-induced constipation.
Licup N; Baumrucker SJ
Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
[TBL] [Abstract][Full Text] [Related]
6. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
[TBL] [Abstract][Full Text] [Related]
8. Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.
Gatti A; Sabato AF
Clin Drug Investig; 2012 May; 32(5):293-301. PubMed ID: 22413747
[TBL] [Abstract][Full Text] [Related]
9. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
Diego L; Atayee R; Helmons P; von Gunten CF
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
[TBL] [Abstract][Full Text] [Related]
10. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
Leppert W
Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
[TBL] [Abstract][Full Text] [Related]
11. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.
Yuan CS
J Support Oncol; 2004; 2(2):111-7; discussion 119-22. PubMed ID: 15328815
[TBL] [Abstract][Full Text] [Related]
12. [Methylnaltrexone. A new approach for therapy of opioid-induced obstipation].
Chappell D; Conzen P
Schmerz; 2009 Oct; 23(5):471-8. PubMed ID: 19690895
[TBL] [Abstract][Full Text] [Related]
13. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.
Slatkin N; Thomas J; Lipman AG; Wilson G; Boatwright ML; Wellman C; Zhukovsky DS; Stephenson R; Portenoy R; Stambler N; Israel R
J Support Oncol; 2009; 7(1):39-46. PubMed ID: 19278178
[TBL] [Abstract][Full Text] [Related]
14. Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study.
Lipman AG; Karver S; Cooney GA; Stambler N; Israel RJ
J Pain Palliat Care Pharmacother; 2011; 25(2):136-45. PubMed ID: 21657861
[TBL] [Abstract][Full Text] [Related]
15. Methylnaltrexone for opioid-induced constipation in advanced illness.
Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
[TBL] [Abstract][Full Text] [Related]
16. Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient.
Lee JM; Mooney J
Clin J Pain; 2012 May; 28(4):338-41. PubMed ID: 21876436
[TBL] [Abstract][Full Text] [Related]
17. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
Jones R; Prommer E; Backstedt D
Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
[TBL] [Abstract][Full Text] [Related]
18. Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms.
Iyer SS; Randazzo BP; Tzanis EL; Schulman SL; Zhang H; Wang W; Manley AL
Value Health; 2011 Jan; 14(1):177-83. PubMed ID: 21211500
[TBL] [Abstract][Full Text] [Related]
19. Methylnaltrexone: MNTX.
Drugs R D; 2006; 7(6):374-8. PubMed ID: 17073520
[TBL] [Abstract][Full Text] [Related]
20. Characterization of abdominal pain during methylnaltrexone treatment of opioid-induced constipation in advanced illness: a post hoc analysis of two clinical trials.
Slatkin NE; Lynn R; Su C; Wang W; Israel RJ
J Pain Symptom Manage; 2011 Nov; 42(5):754-60. PubMed ID: 22045373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]